The years-long effort to yank the drug’s approval offers a case study of the agency’s accelerated approval program, which green-lit Makena in 2011.
© 2020-23 Digest Wire. All rights belong to their respective owners.
Wednesday, October 30, 2024
Battle over pregnancy drug highlights risks of FDA expediting drugs to market
ADVERTISEMENT
Trending
Taijul takes five but South Africa extend dominance
Tony de Zorzi made 177 and David Bedingham 59 as South Africa scored more than 100 runs...
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions